Zacks Investment Research | Sep 12, 2017 10:33PM ET
After Hurricane Irma exited following a lesser-than-estimated impact and North Korea stayed away from any further nuclear missile test, the Wall Street got back its shine.
Furthermore, Apple’s (NASDAQ:AAPL) annual consumer-products event held on Sep 12 is expected to revive investor appetite in the technology space. In fact, the record-high closings of the Dow, S&P 500 and Nasdaq indices on Sep 11 are indicative of the fact that the U.S. equity markets have been performing really well for quite some time now.
Republican Brunt on MedTech Space
While the overall investment world has been gaining prominence, investors in the MedTech industry are unfortunately seeing a reverse trend. This is largely because of the healthcare policy related debacle that had started since the change of President.
After a series of regulatory debacles, the Republicans’ agenda to exterminate the Obamacare failed miserably. Stocks tumbled and things got riskier when the “skinny" repeal bill to partially retract Obamacare fell flat as well.
In this regard, let’s not forget the tax-reform pledges that President Trump had taken to abolish the infamous 2.3% medical device sales tax. Although investor confidence trends up with the hope of ‘enactment of new tax reforms’, we believe the market has not got a whiff of it due to the lack of favorable developments in the regulatory front.
Dental Grapples With Political Issues
Amid such a political conundrum in the MedTech space, the condition of the U.S. dental industry has been getting worse as well. However, this sector has had a stellar performance on the bourse over the last five years, gaining 94.7%, outperforming the S&P 500’s return of just 73%.
Apart from the major political issues that have affected consumer spending in the dental space, there are issues like ease of entrance of dental suppliers, abundance of substitutes, monopoly of suppliers, strict consumer sovereignty and intra-industry rivalry which have been impeding the industry’s growth for quite some time now.
Also, aggressive reimbursement policy adopted by the government and insurers has made it difficult for medical companies to market their products due to increased scrutiny. A notable exception to this trend has been stocks concerning dentistry, since consumers pay a higher percentage of costs in this particular industry. Undoubtedly, dental stocks have been facing the regulatory brunt.
Accordingly, the scenario of the industry is gradually deteriorating and over the last three years, it has just gained 20.6%, much lower than the S&P 500’s return of almost 25%. Furthermore, a discouraging broader industry rank (among Bottom 31% of more than 250 industries) indicates looming concerns for the dental space. We also note that this industry’s projected earnings per share growth rate is 8.7%, lower than the S&P 500’s 9.8%.
5 Dental Stocks to Bet On
Owing to the adversities, market watchers have adopted a bearish stance toward the dental space. However, these are the only five dental stocks that are expected to beat the ongoing MedTech gloom. Apart from a strong Zacks Rank #1 (Strong Buy) or 2 (Buy), these stocks have a favorable estimate revision trend.
VWR Corporation (NASDAQ:VWR) : This Zacks Rank #2 company is an independent worldwide provider of products, services and solutions to laboratory and production facilities. VWR is currently looking forward to long-term synergy benefits from the proposed merger with Avantor. Based on a series of initiatives taken of late, VWR has showed balanced growth in the Americas and EMEA-APAC organically.
Avantor's buyout of VWR is expected to create a major consumables-focused solutions and services provider for the high-growth life sciences and advanced technologies industries. The acquisition will build on the company's strengths, including Avantor's cGMP manufacturing processes, significant exposure to emerging markets and VWR's strong position in the Americas and Europe.
Meanwhile, the company’s recent earnings estimates have been promising. The current year has seen two estimates go higher in the past 60 days, while one next-year estimate moved up in the same time period. This had a nominal impact on the consensus estimate though as both the current and next year consensus estimates have risen 0.5% in the past two months.
VWR Corporation Price and Consensus
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.